Children
Related entities
Findings (50 of 495)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
improvementPhysical activity significantly modified the association between gestational PFOA and cardiometabolic risk scores at age 12: each doubling of PFOA was associated with worse cardiometabolic risk among
Effect: improvement; β: −0.2 (high PA) vs β: 1.4 (low PA) per doubling of PFOA; CI: 95% CI: −1.2, 0.7 (high PA); 95% CI: 0.5, 2.2 (low PA)
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
None
declineChildren of women with increasing depressive symptoms from preconception through postpartum scored significantly lower on an inhibitory control task at age 5 compared to children of women with low-sta
Effect: decline; β = −0.35
Papers (42)
- PMC10024939 · PMC →
- PMC10156903 · PMC →
- PMC2629074 · PMC →
- PMC2865471 · PMC →
- PMC2878893 · PMC →
- PMC2927984 · PMC →
- PMC3196279 · PMC →
- PMC3368997 · PMC →
- PMC3674183 · PMC →
- PMC3746007 · PMC →
- PMC3787136 · PMC →
- PMC3800474 · PMC →
- PMC4122685 · PMC →
- PMC4497929 · PMC →
- PMC4670820 · PMC →
- PMC4925087 · PMC →
- PMC5598352 · PMC →
- PMC5654395 · PMC →
- PMC5654526 · PMC →
- PMC5766393 · PMC →
- PMC5986588 · PMC →
- PMC6093790 · PMC →
- PMC6190831 · PMC →
- PMC6425733 · PMC →
- PMC6587179 · PMC →
- PMC6815700 · PMC →
- PMC6923624 · PMC →
- PMC6992468 · PMC →
- PMC7428151 · PMC →
- PMC7434047 · PMC →
- PMC7611536 · PMC →
- PMC7611818 · PMC →
- PMC7982990 · PMC →
- PMC8344177 · PMC →
- PMC8711723 · PMC →
- PMC8712396 · PMC →
- PMC8957586 · PMC →
- PMC8960403 · PMC →
- PMC9361393 · PMC →
- PMC9383697 · PMC →
- PMC9516351 · PMC →
- PMC9637371 · PMC →